addition
发表于 2025-3-25 06:48:17
http://reply.papertrans.cn/71/7025/702498/702498_21.png
不要不诚实
发表于 2025-3-25 08:23:23
Traumatic Optic Neuropathies,pathy occurs in approximately 0.5% to 5% of closed head injuries. and in 2.5% of patients with maxillofacial trauma and midface fractures.. Loss of consciousness is associated with traumatic optic neuropathy in 40% to 70% of cases.. In closed head injuries, the site of injury causing blindness is of
subacute
发表于 2025-3-25 14:03:19
http://reply.papertrans.cn/71/7025/702498/702498_23.png
悬挂
发表于 2025-3-25 17:30:20
Hereditary Optic Neuropathies, the mitochondrial DNA. The exact worldwide incidence of LHON is unknown, but it is much less prevalent than other optic nerve disorders, such as optic neuritis and ischemic optic neuropathy. Men are affected two to three times more frequently than women..
巨大没有
发表于 2025-3-25 21:38:47
Congenital Disc Anomalies,s disorder reflects its greater recognition by ophthalmologists and possibly the increased incidence of alcohol and drug abuse. It may be unilateral or bilateral, and may occur with or without any associated neurological or ocular abnormalities..
Jacket
发表于 2025-3-26 02:51:26
http://reply.papertrans.cn/71/7025/702498/702498_26.png
神刊
发表于 2025-3-26 06:01:14
http://reply.papertrans.cn/71/7025/702498/702498_27.png
削减
发表于 2025-3-26 08:49:49
http://reply.papertrans.cn/71/7025/702498/702498_28.png
珍奇
发表于 2025-3-26 13:27:07
e book focusing on the understanding of Fluorescein angiogra.Fluorescein angiography is an indispensable tool in modern ophthalmology. It is founded on the evaluation of phenomena related to the behavior intravenously administered sodium fluorescein in the tissues of the ocular fundus..Commonly, tex
肌肉
发表于 2025-3-26 19:58:53
Jane W. Chan MDbeitet und enthält zwei neue Kapitel..Includes supplementary.Thema des Buches sind grundlegende Wettbewerbsstrategien von Unternehmen zur Kostenführerschaft und zur Produktdifferenzierung. Dazu gehören (aus kurzfristiger Sicht) Absatz- und Preisstrategien und (aus langfristiger Sicht) Innovations-,